Lyme Diagnostics IGeneX specializes in Lyme disease and tick-borne illnesses with a long track record of improved diagnostic accuracy, suggesting opportunities to collaborate on advanced testing panels, physician education programs, and referral partnerships to expand diagnostic reach.

Clinical Training The company’s emphasis on training physicians to become Lyme literate signals a potential for developing continuing medical education (CME) offerings, content partnerships, and credentialing programs that could be bundled with lab services for healthcare networks.

Mid-market Focus With a workforce of 11-50 and revenue in the $10–$25M range, IGeneX sits between smaller specialized labs and larger national providers, presenting a sales opportunity for scalable laboratory automation, workflow integration, and compliant data exchange within mid-market health systems.

Tech Stack Synergy Existing technologies (AWS, Google Cloud, WordPress, Shopify, iCIMS, Brevo, Piwik PRO) indicate receptiveness to cloud-based solutions, marketing automation, e-commerce enabled services, and data analytics integrations that could streamline ordering, patient outreach, and reporting.

Growth Potential Revenue visibility and credible leadership in niche diagnostics position IGeneX for expansion through partner networks, managed services, and strategic collaborations with larger diagnostics players or integrated health networks seeking to broaden Lyme-related testing offerings.